Phase 1 Study of Safety, Tolerability and Pharmacokinetics of SPR994
Clinical trial NCT03395249 · COMPLETED
Trial details
- NCT number
- NCT03395249
- Sponsor
- Spero Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2018-08-02
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.